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Abstract
Background: Hepatitis B virus infection has become a 
global public health problem. In Nigeria, several studies 
from different parts of the country have confirmed the 
endemicity of the infection. This study seeks examine the 
seroprevalence of Hepatitis B viral infection among 
patients attending Aminu Kano Teaching Hospital in Kano 
metropolis. 
Method: This is a retrospective study in which patients 
tested for hepatitis B virus using hepatitis B surface 
antigen (HBsAg) as a marker were reviewed over 3 years. 
A total of 6,395 patients comprising of 4,040 males and 
2,355 females including adults and children were tested 
for HBsAg from January 2004 to December 2006. Over 
this period, 1,509 sera were tested in 2004, 2,322 in 2005 
and 2,564 in 2006.
Results: Among the 6,395 patients, 703(11.4%) 
comprising of 240 (10.2%) females and 490 (12.1%) 
males were positive for HBsAg. The highest prevalence 
was seen at the extremes of life in which 19.4% and 16.9% 
were seen among patients below 10years and above 50 
years respectively. The yearly trend of HBV surface 
antigenemia was 220 (14.6%) in 2004, 235 (10.1%) in 
2005 and 275 (10.7%) in 2006. 
Conclusion: We conclude that the prevalence of HBsAg 
among patients attending Aminu Kano Teaching Hospital, 
Kano is high and highest prevalence is seen at the 
extremes of life. 
Key Words: Hepatitis B, Hepatitis B surface antigen 
(HBsAg), Kano.
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Introduction
Hepatitis B virus (HBV) infection has become a global 
public health problem. One in six of the world population is 
infected with the virus and carrier rate is estimated to be 
1
350 million people . An estimated 150,000  450,000 
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people are infected yearly during the past two decades 
2in United States of America . 
HBV is particularly endemic in sub-Saharan Africa 
which often leads to significant morbidity and mortality 
and a good number of those infected may be 
3
asymptomatic prior to development of complications . In 
Nigeria, several studies from different parts of the 
4-country have confirmed the endemicity of the infection
8
. A prevalence rate of above 25% of chronic hepatitis B 
carrier state have been found in some study 
5,8populations . An increasing trend of HBV antigenemia 
was previously reported among patients in Aminu Kano 
4Teaching Hospital, Kano in Nigeria . Infants infected 
perinatally from their HBV positive mother have 90% 
9
risk of becoming chronic carriers . Furthermore, about 
90% of preschool children infected with HBV failed to 
achieve clearance and develop persistent HBV 
infection while majority of adults infected achieved 
clearance with only 5  10% becoming potential chronic 
10carriers . 
Safe and effective vaccine against HBV is available and 
has been recommended for individuals at risk of 
8infection . Nigerian government has introduced routine 
childhood immunization and mandatory screening of 
blood for transfusions in order to half the transmission of 
hepatitis B virus. Although not enforced, vaccination of 
healthcare workers was also recommended. 
This present study seeks to examine the prevalence 
rate of hepatitis B virus infection among patients 
attending Aminu Kano Teaching Hospital over a three 
year period starting from January 2004 to December 
2006. 
Patients and Method
This is a retrospective study in which results of hepatitis 
B screening tests done in the Medical Microbiology 
laboratories of Aminu Kano Teaching Hospital (AKTH) 
between January 2004 and December 2006 were 
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reviewed. Included in this study were all patients sent for 
the first time for Hepatitis B tests from various hospital 
clinics of the teaching hospital. Patients who have been 
previously confirmed Hepatitis B virus infected were 
excluded from the study. Blood donors were normally not 
screened in the Microbiology laboratories and so were not 
included in the review. In the Medical Microbiology 
laboratories, testing was done initially using latex 
agglutination technique and positive samples were 
repeated using ELISA technique (Pathogyne Omega 
Diagnostics, UK) for confirmation. Standard positive and 
negative controls from manufacturers were used in testing 
each batch of samples. The study was conducted when 
the 1st author was the head of the Medical Microbiology 
department, AKTH Kano. Since this is a retrospective 
study, consent to review the data was obtained only from 
the current Head of Department of Medical Microbiology 
of the Teaching Hospital. 
The results were analyzed using SPSS 11.0 statistical 
2software; Chi-square (X ) was used to compare 
association between proportions and P-values <0.05 was 
considered significant at 95.0% confidence level. 
Results
A total of 6,395 patients tested from 2004 to 2006 for 
hepatitis B virus using HBsAg as marker were reviewed.  
Among these, 4,040 were males while 2,355 were 
females. 
Figure I showed the gender distribution of hepatitis B 
virus surface antigenemia among hospital patients. Out of 
the total 6,395 patients tested, 730 (11.4%) were positive. 
Among these, 490 (12.1%) males and 240 (10.2%) 
females were positive giving a male to female ratio of 
1.2:1.
Figure II showed the yearly trend of hepatitis B virus 
surface antigenemia among hospital patients. In 2004, 
1,509 sera were tested and 220 were positive; in 2005, 
2,322 sera were tested and 235 sera were positive while in 
2006, 2,564 were tested and 275 were positive. The 
yearly prevalence was 14.6%, 10.1% and 10.7% for 2004, 
2005 and 2006 respectively.
Table 1 showed age group distribution of patients with 
hepatitis B virus surface antigenemia. Most patients were 
seen in age bracket 21-30 years (2,060), the rates of 
positive antigenamia were 18.2%, 11.2%, 11.6% for age 
groups <10 yrs, 11-20yrs and 21  30 years respectively. 
While 10.8%, 9.8% and 16.2% were recorded for aged 
group 31  40 years, 41  50 years and > 50 years 
respectively.
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Fig 1: Gender distribution of Seroprevalence of Hepatitis B 
virus surface antigen among patients attending Aminu Kano 
Teaching Hospital, Kano.
Fig 2: Yearly seroprevalence of Hepatitis B virus surface 
antigen among patients attending Aminu Kano Teaching 
Hospital, Kano
Table I: Age distribution of hepatitis B virus Seroprevalence among 
patients attending Aminu Kano Teaching Hospital, Kano.
Age in years  No. Tested  No. Positive Percentage
<10



























41-50 1118 110 9.8
>50 358 58 16.2
Total 6395 730 11.4
Discussion
High endemicity of HBV was defined as HBsAg 
prevalence of more than 7% in a given population. The 
observed yearly prevalence of 14.6%, 10.1% and 
10.7% for 2004, 2005 and 2006 respectively clearly 
indicate that HBV infection is highly endemic in Kano. 
10This finding is similar to those reported from Benin , 
11 5,12
Ibadan and Jos . Our finding showed a higher 
13
prevalence than those reported from Nnewi  and 
14  Nsukka . The latter reports were from apparently 
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healthy subjects and may explain the marked reduction in 
the prevalence rates observed. 
A slightly higher HBsAg seroprevalence recorded in the 
males (male to female ratio of 1.2: 1) in this study is similar 
to other findings in which the frequency of HBsAg carrier 
6, 15, 16state occurs more in males than females . The 
similarity in the mode of exposure to HBV across the 
genders in the study population may account for the 
prevalence observed.
The age prevalence distribution of which prevalence 
rates of 19.4% and 16.9% reported in patients of age 
groups zero to 10years and more than 50 years of age 
13
respectively in this study is similar to findings from Nnewi  
10 and Benin  where higher rates were recorded in age 
groups less than 10 years and more than 50 years. A high 
prevalence rate at age less than 10years may suggest 
vertical mode of transmission which is similar to findings 
in Asia where vertical transmission is the main mode of 
17infection . Since a declining trend in the rate of HBV in the 
US has been partly related to immunization strategies 
2employed , there is an urgent need to intensify 
vaccination of all healthy mothers to limit further spread of 
the virus. On the other hand, high prevalence observed in 
adults over 50years of age imply horizontal mode of 
transmission. Sexual contact with infected individuals, 
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transfusion with infected blood, scarification, herbal 
marks, tattooing and formites are important in horizontal 
transmission of HBV. 
Recent report has it that silent epidemic of HBV in India 
in which 'Occult hepatitis' defined by lack of serological 
markers but the presence of HBV DNA detectable only 
by polymerase chain reaction (PCR) may be 
responsible for transfusion related transmission of 
17
hepatitis from screened blood . Therefore, there is 
need to make PCR functional in our laboratories and 
provide reagents for testing for other serological 
markers of HBV in order to increase diagnostic 
efficiency of the virus. 
We conclude that the decline in the trend of HBV 
through the 3 years among the study population is not 
continuous despite measures introduced to half the 
spread of the virus.  
We therefore recommend an urgently need to make 
PCR functionally available for the diagnosis of HBV. 
Other reagents for serological detection of HBV should 
also the routinely available in Kano in order to 
conclusively diagnose the virus. Finally, uniform 
childhood immunization as well as vaccination of those 
at risk in work places should continue to be enforced.
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